-
1
-
-
2642549867
-
The obesity epidemic
-
Abelson P, Kennedy D. The obesity epidemic. Science. 2004;304:1413.
-
(2004)
Science
, vol.304
, pp. 1413
-
-
Abelson, P.1
Kennedy, D.2
-
2
-
-
62849107573
-
Body-mass index and cause-specific mortality in 900 000 adults: Collaborative analyses of 57 prospective studies
-
Whitlock G, Lewington S, Sherliker P, Clarke R, Emberson J, Halsey J, Qizilbash N, Collins R, Peto R. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet. 2009;373:1083-1096.
-
(2009)
Lancet
, vol.373
, pp. 1083-1096
-
-
Whitlock, G.1
Lewington, S.2
Sherliker, P.3
Clarke, R.4
Emberson, J.5
Halsey, J.6
Qizilbash, N.7
Collins, R.8
Peto, R.9
-
3
-
-
79951997878
-
Association between body-mass index and risk of death in more than 1 million Asians
-
Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F, Tamakoshi A, Gao YT, Wang R, Shu XO, Tsuji I, Kuriyama S, Tanaka H, Satoh H, Chen CJ, Yuan JM, Yoo KY, Ahsan H, Pan WH, Gu D, Pednekar MS, Sauvaget C, Sasazuki S, Sairenchi T, Yang G, Xiang YB, Nagai M, Suzuki T, Nishino Y, You SL, Koh WP, Park SK, Chen Y, Shen CY, Thornquist M, Feng Z, Kang D, Boffetta P, Potter JD. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011;364:719-729.
-
(2011)
N Engl J Med.
, vol.364
, pp. 719-729
-
-
Zheng, W.1
McLerran, D.F.2
Rolland, B.3
Zhang, X.4
Inoue, M.5
Matsuo, K.6
He, J.7
Gupta, P.C.8
Ramadas, K.9
Tsugane, S.10
Irie, F.11
Tamakoshi, A.12
Gao, Y.T.13
Wang, R.14
Shu, X.O.15
Tsuji, I.16
Kuriyama, S.17
Tanaka, H.18
Satoh, H.19
Chen, C.J.20
Yuan, J.M.21
Yoo, K.Y.22
Ahsan, H.23
Pan, W.H.24
Gu, D.25
Pednekar, M.S.26
Sauvaget, C.27
Sasazuki, S.28
Sairenchi, T.29
Yang, G.30
Xiang, Y.B.31
Nagai, M.32
Suzuki, T.33
Nishino, Y.34
You, S.L.35
Koh, W.P.36
Park, S.K.37
Chen, Y.38
Shen, C.Y.39
Thornquist, M.40
Feng, Z.41
Kang, D.42
Boffetta, P.43
Potter, J.D.44
more..
-
4
-
-
78649747039
-
Body-mass index and mortality among 1.46 million white adults
-
Berrington de Gonzalez A, Hartge P, Cerhan JR, Flint AJ, Hannan L, MacInnis RJ, Moore SC, Tobias GS, Anton-Culver H, Freeman LB, Beeson WL, Clipp SL, English DR, Folsom AR, Freedman DM, Giles G, Hakansson N, Henderson KD, Hoffman-Bolton J, Hoppin JA, Koenig KL, Lee IM, Linet MS, Park Y, Pocobelli G, Schatzkin A, Sesso HD, Weiderpass E, Willcox BJ, Wolk A, Zeleniuch-Jacquotte A, Willett WC, Thun MJ. Body-mass index and mortality among 1.46 million white adults. N Engl J Med. 2010;363:2211-2219.
-
(2010)
N Engl J Med.
, vol.363
, pp. 2211-2219
-
-
Berrington De Gonzalez, A.1
Hartge, P.2
Cerhan, J.R.3
Flint, A.J.4
Hannan, L.5
Macinnis, R.J.6
Moore, S.C.7
Tobias, G.S.8
Anton-Culver, H.9
Freeman, L.B.10
Beeson, W.L.11
Clipp, S.L.12
English, D.R.13
Folsom, A.R.14
Freedman, D.M.15
Giles, G.16
Hakansson, N.17
Henderson, K.D.18
Hoffman-Bolton, J.19
Hoppin, J.A.20
Koenig, K.L.21
Lee, I.M.22
Linet, M.S.23
Park, Y.24
Pocobelli, G.25
Schatzkin, A.26
Sesso, H.D.27
Weiderpass, E.28
Willcox, B.J.29
Wolk, A.30
Zeleniuch-Jacquotte, A.31
Willett, W.C.32
Thun, M.J.33
more..
-
5
-
-
33747861026
-
Bodymass index and mortality in Korean men and women
-
Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM. Bodymass index and mortality in Korean men and women. N Engl J Med. 2006;355:779-787.
-
(2006)
N Engl J Med
, vol.355
, pp. 779-787
-
-
Jee, S.H.1
Sull, J.W.2
Park, J.3
Lee, S.Y.4
Ohrr, H.5
Guallar, E.6
Samet, J.M.7
-
6
-
-
33747135682
-
Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies
-
Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368:666-678.
-
(2006)
Lancet
, vol.368
, pp. 666-678
-
-
Romero-Corral, A.1
Montori, V.M.2
Somers, V.K.3
Korinek, J.4
Thomas, R.J.5
Allison, T.G.6
Mookadam, F.7
Lopez-Jimenez, F.8
-
7
-
-
33845348932
-
ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: Analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry
-
Fonarow GC, Srikanthan P, Costanzo MR, Cintron GB, Lopatin M; ADHERE Scientific Advisory Committee and Investigators. An obesity paradox in acute heart failure: analysis of body mass index and inhospital mortality for 108,927 patients in the Acute Decompensated Heart Failure National Registry. Am Heart J. 2007;153:74-81.
-
(2007)
Am Heart J
, vol.153
, pp. 74-81
-
-
Fonarow, G.C.1
Srikanthan, P.2
Costanzo, M.R.3
Cintron, G.B.4
Lopatin, M.5
-
8
-
-
45549097014
-
Body mass index and mortality in heart failure: A metaanalysis
-
Oreopoulos A, Padwal R, Kalantar-Zadeh K, Fonarow GC, Norris CM, McAlister FA. Body mass index and mortality in heart failure: a metaanalysis. Am Heart J. 2008;156:13-22.
-
(2008)
Am Heart J
, vol.156
, pp. 13-22
-
-
Oreopoulos, A.1
Padwal, R.2
Kalantar-Zadeh, K.3
Fonarow, G.C.4
Norris, C.M.5
McAlister, F.A.6
-
9
-
-
0242361644
-
Body mass index: A risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease
-
Wolk R, Berger P, Lennon RJ, Brilakis ES, Somers VK. Body mass index: a risk factor for unstable angina and myocardial infarction in patients with angiographically confirmed coronary artery disease. Circulation. 2003;108:2206-2211.
-
(2003)
Circulation
, vol.108
, pp. 2206-2211
-
-
Wolk, R.1
Berger, P.2
Lennon, R.J.3
Brilakis, E.S.4
Somers, V.K.5
-
10
-
-
69249219296
-
Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy
-
Shuldiner AR, O'Connell JR, Bliden KP, Gandhi A, Ryan K, Horenstein RB, Damcott CM, Pakyz R, Tantry US, Gibson Q, Pollin TI, Post W, Parsa A, Mitchell BD, Faraday N, Herzog W, Gurbel PA. Association of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapy. JAMA. 2009;302:849-857.
-
(2009)
JAMA
, vol.302
, pp. 849-857
-
-
Shuldiner, A.R.1
O'connell, J.R.2
Bliden, K.P.3
Gandhi, A.4
Ryan, K.5
Horenstein, R.B.6
Damcott, C.M.7
Pakyz, R.8
Tantry, U.S.9
Gibson, Q.10
Pollin, T.I.11
Post, W.12
Parsa, A.13
Mitchell, B.D.14
Faraday, N.15
Herzog, W.16
Gurbel, P.A.17
-
11
-
-
0037138577
-
The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: The obesity paradox?
-
Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr. The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol. 2002;39:578-584.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 578-584
-
-
Gruberg, L.1
Weissman, N.J.2
Waksman, R.3
Fuchs, S.4
Deible, R.5
Pinnow, E.E.6
Ahmed, L.M.7
Kent, K.M.8
Pichard, A.D.9
Suddath, W.O.10
Satler, L.F.11
Lindsay Jr., J.12
-
12
-
-
33947581443
-
Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction
-
Mehta L, Devlin W, McCullough PA, O'Neill WW, Skelding KA, Stone GW, Boura JA, Grines CL. Impact of body mass index on outcomes after percutaneous coronary intervention in patients with acute myocardial infarction. Am J Cardiol. 2007;99:906-910.
-
(2007)
Am J Cardiol
, vol.99
, pp. 906-910
-
-
Mehta, L.1
Devlin, W.2
McCullough, P.A.3
O'neill, W.W.4
Skelding, K.A.5
Stone, G.W.6
Boura, J.A.7
Grines, C.L.8
-
13
-
-
78049441468
-
Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry
-
MIG (Melbourne Interventional Group) Registry
-
Lancefield T, Clark DJ, Andrianopoulos N, Brennan AL, Reid CM, Johns J, Freeman M, Charter K, Duffy SJ, Ajani AE, Proietto J, Farouque O; MIG (Melbourne Interventional Group) Registry. Is there an obesity paradox after percutaneous coronary intervention in the contemporary era? An analysis from a multicenter Australian registry. J Am Coll Cardiol Cardiovasc Interv. 2010;3:660-668.
-
(2010)
J Am Coll Cardiol Cardiovasc Interv.
, vol.3
, pp. 660-668
-
-
Lancefield, T.1
Clark, D.J.2
Andrianopoulos, N.3
Brennan, A.L.4
Reid, C.M.5
Johns, J.6
Freeman, M.7
Charter, K.8
Duffy, S.J.9
Ajani, A.E.10
Proietto, J.11
Farouque, O.12
-
14
-
-
74549117766
-
Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention
-
Hastie CE, Padmanabhan S, Slack R, Pell AC, Oldroyd KG, Flapan AD, Jennings KP, Irving J, Eteiba H, Dominiczak AF, Pell JP. Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention. Eur Heart J. 2010;31:222-226.
-
(2010)
Eur Heart J.
, vol.31
, pp. 222-226
-
-
Hastie, C.E.1
Padmanabhan, S.2
Slack, R.3
Pell, A.C.4
Oldroyd, K.G.5
Flapan, A.D.6
Jennings, K.P.7
Irving, J.8
Eteiba, H.9
Dominiczak, A.F.10
Pell, J.P.11
-
15
-
-
82955189273
-
Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry)
-
Das SR, Alexander KP, Chen AY, Powell-Wiley TM, Diercks DB, Peterson ED, Roe MT, de Lemos JA. Impact of body weight and extreme obesity on the presentation, treatment, and in-hospital outcomes of 50,149 patients with ST-Segment elevation myocardial infarction results from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol. 2011;58:2642-2650.
-
(2011)
J Am Coll Cardiol.
, vol.58
, pp. 2642-2650
-
-
Das, S.R.1
Alexander, K.P.2
Chen, A.Y.3
Powell-Wiley, T.M.4
Diercks, D.B.5
Peterson, E.D.6
Roe, M.T.7
De Lemos, J.A.8
-
16
-
-
84857604732
-
No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: Results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry
-
DES.DE (German Drug- Eluting Stent) Study Group
-
Akin I, Tölg R, Hochadel M, Bergmann MW, Khattab AA, Schneider S, Senges J, Kuck KH, Richardt G, Nienaber CA; DES.DE (German Drug- Eluting Stent) Study Group. No evidence of "obesity paradox" after treatment with drug-eluting stents in a routine clinical practice: results from the prospective multicenter German DES.DE (German Drug-Eluting Stent) Registry. J Am Coll Cardiol Cardiovasc Interv. 2012;5:162-169.
-
(2012)
J Am Coll Cardiol Cardiovasc Interv.
, vol.5
, pp. 162-169
-
-
Akin, I.1
Tölg, R.2
Hochadel, M.3
Bergmann, M.W.4
Khattab, A.A.5
Schneider, S.6
Senges, J.7
Kuck, K.H.8
Richardt, G.9
Nienaber, C.A.10
-
17
-
-
77957558782
-
Comparison of zotarolimus- eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: The ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxeleluting stent for coronary lesions) randomized trial
-
Park DW, Kim YH, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Seong IW, Lee JH, Tahk SJ, Jeong MH, Jang Y, Cheong SS, Yang JY, Lim DS, Seung KB, Chae JK, Hur SH, Lee SG, Yoon J, Lee NH, Choi YJ, Kim HS, Kim KS, Kim HS, Hong TJ, Park HS, Park SJ. Comparison of zotarolimus- eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxeleluting stent for coronary lesions) randomized trial. J Am Coll Cardiol. 2010;56:1187-1195.
-
(2010)
J Am Coll Cardiol.
, vol.56
, pp. 1187-1195
-
-
Park, D.W.1
Kim, Y.H.2
Yun, S.C.3
Kang, S.J.4
Lee, S.W.5
Lee, C.W.6
Park, S.W.7
Seong, I.W.8
Lee, J.H.9
Tahk, S.J.10
Jeong, M.H.11
Jang, Y.12
Cheong, S.S.13
Yang, J.Y.14
Lim, D.S.15
Seung, K.B.16
Chae, J.K.17
Hur, S.H.18
Lee, S.G.19
Yoon, J.20
Lee, N.H.21
Choi, Y.J.22
Kim, H.S.23
Kim, K.S.24
Kim, H.S.25
Hong, T.J.26
Park, H.S.27
Park, S.J.28
more..
-
18
-
-
72049099355
-
Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction
-
ZESTAMI Investigators
-
Lee CW, Park DW, Lee SH, Kim YH, Hong MK, Kim JJ, Park SW, Yun SC, Seong IW, Lee JH, Lee NH, Cho YH, Cheong SS, Lim DS, Yang JY, Lee SG, Kim KS, Yoon J, Jeong MH, Seung KB, Hong TJ, Park SJ; ZESTAMI Investigators. Comparison of the efficacy and safety of zotarolimus-, sirolimus-, and paclitaxel-eluting stents in patients with ST-elevation myocardial infarction. Am J Cardiol. 2009;104:1370-1376.
-
(2009)
Am J Cardiol
, vol.104
, pp. 1370-1376
-
-
Lee, C.W.1
Park, D.W.2
Lee, S.H.3
Kim, Y.H.4
Hong, M.K.5
Kim, J.J.6
Park, S.W.7
Yun, S.C.8
Seong, I.W.9
Lee, J.H.10
Lee, N.H.11
Cho, Y.H.12
Cheong, S.S.13
Lim, D.S.14
Yang, J.Y.15
Lee, S.G.16
Kim, K.S.17
Yoon, J.18
Jeong, M.H.19
Seung, K.B.20
Hong, T.J.21
Park, S.J.22
more..
-
19
-
-
33751014542
-
Sirolimuseluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease
-
Long-DES-II Study Investigators
-
Kim YH, Park SW, Lee SW, Park DW, Yun SC, Lee CW, Hong MK, Kim HS, Ko JK, Park JH, Lee JH, Choi SW, Seong IW, Cho YH, Lee NH, Kim JH, Chun KJ, Park SJ; Long-DES-II Study Investigators. Sirolimuseluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease. Circulation. 2006;114:2148-2153.
-
(2006)
Circulation
, vol.114
, pp. 2148-2153
-
-
Kim, Y.H.1
Park, S.W.2
Lee, S.W.3
Park, D.W.4
Yun, S.C.5
Lee, C.W.6
Hong, M.K.7
Kim, H.S.8
Ko, J.K.9
Park, J.H.10
Lee, J.H.11
Choi, S.W.12
Seong, I.W.13
Cho, Y.H.14
Lee, N.H.15
Kim, J.H.16
Chun, K.J.17
Park, S.J.18
-
20
-
-
80054968140
-
Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: A randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions with Drug-Eluting Stent-III) Trial
-
Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Seung KB, Yang TH, Lee SG, Lee JH, Seong IW, Cheong SS, Lee BK, Lee NH, Lee SW, Lee SW, Lee K, Kim HS, Jeon DS, Kim MK, Nah DY, Tahk SJ, Park SJ. Comparison of everolimus- and sirolimus-eluting stents in patients with long coronary artery lesions: a randomized LONG-DES-III (Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-III) Trial. J Am Coll Cardiol Cardiovasc Interv. 2011;4:1096-1103.
-
(2011)
J Am Coll Cardiol Cardiovasc Interv.
, vol.4
, pp. 1096-1103
-
-
Park, D.W.1
Kim, Y.H.2
Song, H.G.3
Ahn, J.M.4
Kim, W.J.5
Lee, J.Y.6
Kang, S.J.7
Lee, S.W.8
Lee, C.W.9
Park, S.W.10
Yun, S.C.11
Seung, K.B.12
Yang, T.H.13
Lee, S.G.14
Lee, J.H.15
Seong, I.W.16
Cheong, S.S.17
Lee, B.K.18
Lee, N.H.19
Lee, S.W.20
Lee, S.W.21
Lee, K.22
Kim, H.S.23
Jeon, D.S.24
Kim, M.K.25
Nah, D.Y.26
Tahk, S.J.27
Park, S.J.28
more..
-
21
-
-
84868641244
-
Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: A randomized LONG-DES IV trial
-
Ahn JM, Park DW, Kim YH, Song H, Cho YR, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Han S, Lee SY, Lee BK, Cho JH, Yang TH, Lee NH, Yang JY, Park JS, Shin WY, Kim MH, Bae JH, Kim MK, Yoon J, Park SJ. Comparison of resolute zotarolimus-eluting stents and sirolimus-eluting stents in patients with de novo long coronary artery lesions: a randomized LONG-DES IV trial. Circ Cardiovasc Interv. 2012;5:633-640.
-
(2012)
Circ Cardiovasc Interv.
, vol.5
, pp. 633-640
-
-
Ahn, J.M.1
Park, D.W.2
Kim, Y.H.3
Song, H.4
Cho, Y.R.5
Kim, W.J.6
Lee, J.Y.7
Kang, S.J.8
Lee, S.W.9
Lee, C.W.10
Park, S.W.11
Yun, S.C.12
Han, S.13
Lee, S.Y.14
Lee, B.K.15
Cho, J.H.16
Yang, T.H.17
Lee, N.H.18
Yang, J.Y.19
Park, J.S.20
Shin, W.Y.21
Kim, M.H.22
Bae, J.H.23
Kim, M.K.24
Yoon, J.25
Park, S.J.26
more..
-
22
-
-
80052170634
-
Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): Results from the ESSENCE-DIABETES trial
-
ESSENCE-DIABETES Study Investigators
-
Kim WJ, Lee SW, Park SW, Kim YH, Yun SC, Lee JY, Park DW, Kang SJ, Lee CW, Lee JH, Choi SW, Seong IW, Lee BK, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Park WJ, Kim HS, Chae JK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Choi YJ, Cheong SS, Yang TH, Jang JS, Her SH, Park SJ; ESSENCE-DIABETES Study Investigators. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial. Circulation. 2011;124:886-892.
-
(2011)
Circulation.
, vol.124
, pp. 886-892
-
-
Kim, W.J.1
Lee, S.W.2
Park, S.W.3
Kim, Y.H.4
Yun, S.C.5
Lee, J.Y.6
Park, D.W.7
Kang, S.J.8
Lee, C.W.9
Lee, J.H.10
Choi, S.W.11
Seong, I.W.12
Lee, B.K.13
Lee, N.H.14
Cho, Y.H.15
Shin, W.Y.16
Lee, S.J.17
Lee, S.W.18
Hyon, M.S.19
Bang, D.W.20
Park, W.J.21
Kim, H.S.22
Chae, J.K.23
Lee, K.24
Park, H.K.25
Park, C.B.26
Lee, S.G.27
Kim, M.K.28
Park, K.H.29
Choi, Y.J.30
Cheong, S.S.31
Yang, T.H.32
Jang, J.S.33
Her, S.H.34
Park, S.J.35
more..
-
23
-
-
79952435293
-
A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: Results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial
-
DECLARE-LONG II Study Investigators
-
Lee SW, Park SW, Kim YH, Yun SC, Park DW, Lee CW, Kang SJ, Park SJ, Lee JH, Choi SW, Seong IW, Lee NH, Cho YH, Shin WY, Lee SJ, Lee SW, Hyon MS, Bang DW, Choi YJ, Kim HS, Lee BK, Lee K, Park HK, Park CB, Lee SG, Kim MK, Park KH, Park WJ; DECLARE-LONG II Study Investigators. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial. J Am Coll Cardiol. 2011;57:1264-1270.
-
(2011)
J Am Coll Cardiol.
, vol.57
, pp. 1264-1270
-
-
Lee, S.W.1
Park, S.W.2
Kim, Y.H.3
Yun, S.C.4
Park, D.W.5
Lee, C.W.6
Kang, S.J.7
Park, S.J.8
Lee, J.H.9
Choi, S.W.10
Seong, I.W.11
Lee, N.H.12
Cho, Y.H.13
Shin, W.Y.14
Lee, S.J.15
Lee, S.W.16
Hyon, M.S.17
Bang, D.W.18
Choi, Y.J.19
Kim, H.S.20
Lee, B.K.21
Lee, K.22
Park, H.K.23
Park, C.B.24
Lee, S.G.25
Kim, M.K.26
Park, K.H.27
Park, W.J.28
more..
-
24
-
-
77951001904
-
Duration of dual antiplatelet therapy after implantation of drug-eluting stents
-
Park SJ, Park DW, Kim YH, Kang SJ, Lee SW, Lee CW, Han KH, Park SW, Yun SC, Lee SG, Rha SW, Seong IW, Jeong MH, Hur SH, Lee NH, Yoon J, Yang JY, Lee BK, Choi YJ, Chung WS, Lim DS, Cheong SS, Kim KS, Chae JK, Nah DY, Jeon DS, Seung KB, Jang JS, Park HS, Lee K. Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med. 2010;362:1374-1382.
-
(2010)
N Engl J Med.
, vol.362
, pp. 1374-1382
-
-
Park, S.J.1
Park, D.W.2
Kim, Y.H.3
Kang, S.J.4
Lee, S.W.5
Lee, C.W.6
Han, K.H.7
Park, S.W.8
Yun, S.C.9
Lee, S.G.10
Rha, S.W.11
Seong, I.W.12
Jeong, M.H.13
Hur, S.H.14
Lee, N.H.15
Yoon, J.16
Yang, J.Y.17
Lee, B.K.18
Choi, Y.J.19
Chung, W.S.20
Lim, D.S.21
Cheong, S.S.22
Kim, K.S.23
Chae, J.K.24
Nah, D.Y.25
Jeon, D.S.26
Seung, K.B.27
Jang, J.S.28
Park, H.S.29
Lee, K.30
more..
-
25
-
-
54149089301
-
Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents
-
Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ. Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents. J Am Coll Cardiol Cardiovasc Interv. 2008;1:494-503.
-
(2008)
J Am Coll Cardiol Cardiovasc Interv
, vol.1
, pp. 494-503
-
-
Park, D.W.1
Yun, S.C.2
Lee, S.W.3
Kim, Y.H.4
Lee, C.W.5
Hong, M.K.6
Cheong, S.S.7
Kim, J.J.8
Park, S.W.9
Park, S.J.10
-
26
-
-
82955189275
-
A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation
-
Park DW, Lee SW, Yun SC, Song HG, Ahn JM, Lee JY, Kim WJ, Kang SJ, Kim YH, Lee CW, Park SW, Park SJ. A point-of-care platelet function assay and C-reactive protein for prediction of major cardiovascular events after drug-eluting stent implantation. J Am Coll Cardiol. 2011;58:2630-2639.
-
(2011)
J Am Coll Cardiol.
, vol.58
, pp. 2630-2639
-
-
Park, D.W.1
Lee, S.W.2
Yun, S.C.3
Song, H.G.4
Ahn, J.M.5
Lee, J.Y.6
Kim, W.J.7
Kang, S.J.8
Kim, Y.H.9
Lee, C.W.10
Park, S.W.11
Park, S.J.12
-
27
-
-
84864590466
-
Outcomes after unrestricted use of everolimus-eluting and sirolimuseluting stents in routine clinical practice: A multicenter, prospective cohort study
-
IRIS-DES Investigators
-
Park DW, Kim YH, Song HG, Ahn JM, Kim WJ, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Yun SC, Her SH, Hur SH, Park JS, Kim MK, Choi YS, Kim HS, Cho JH, Lee SG, Park YW, Jeong MH, Lee BK, Lee NH, Lim DS, Yoon J, Seung KB, Shin WY, Rha SW, Kim KS, Tahk SJ, Park BE, Ahn T, Yang JY, Jeong YS, Rhew JH, Park SJ; IRIS-DES Investigators. Outcomes after unrestricted use of everolimus-eluting and sirolimuseluting stents in routine clinical practice: a multicenter, prospective cohort study. Circ Cardiovasc Interv. 2012;5:365-371.
-
(2012)
Circ Cardiovasc Interv.
, vol.5
, pp. 365-371
-
-
Park, D.W.1
Kim, Y.H.2
Song, H.G.3
Ahn, J.M.4
Kim, W.J.5
Lee, J.Y.6
Kang, S.J.7
Lee, S.W.8
Lee, C.W.9
Park, S.W.10
Yun, S.C.11
Her, S.H.12
Hur, S.H.13
Park, J.S.14
Kim, M.K.15
Choi, Y.S.16
Kim, H.S.17
Cho, J.H.18
Lee, S.G.19
Park, Y.W.20
Jeong, M.H.21
Lee, B.K.22
Lee, N.H.23
Lim, D.S.24
Yoon, J.25
Seung, K.B.26
Shin, W.Y.27
Rha, S.W.28
Kim, K.S.29
Tahk, S.J.30
Park, B.E.31
Ahn, T.32
Yang, J.Y.33
Jeong, Y.S.34
Rhew, J.H.35
Park, S.J.36
more..
-
28
-
-
36548998846
-
Universal definition of myocardial infarction
-
Thygesen K, Alpert JS, White HD, Jaffe AS, Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, Clemmensen PM, Dellborg M, Hod H, Porela P, Underwood R, Bax JJ, Beller GA, Bonow R, Van der Wall EE, Bassand JP, Wijns W, Ferguson TB, Steg PG, Uretsky BF, Williams DO, Armstrong PW, Antman EM, Fox KA, Hamm CW, Ohman EM, Simoons ML, Poole-Wilson PA, Gurfinkel EP, Lopez-Sendon JL, Pais P, Mendis S, Zhu JR, Wallentin LC, Fernandez-Aviles F, Fox KM, Parkhomenko AN, Priori SG, Tendera M, Voipio-Pulkki LM, Vahanian A, Camm AJ, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Widimsky P, Zamorano JL, Morais J, Brener S, Harrington R, Morrow D, Lim M, Martinez-Rios MA, Steinhubl S, Levine GN, Gibler WB, Goff D, Tubaro M, Dudek D, Al-Attar N. Universal definition of myocardial infarction. Circulation. 2007;116:2634-2653.
-
(2007)
Circulation
, vol.116
, pp. 2634-2653
-
-
Thygesen, K.1
Alpert, J.S.2
White, H.D.3
Jaffe, A.S.4
Apple, F.S.5
Galvani, M.6
Katus, H.A.7
Newby, L.K.8
Ravkilde, J.9
Chaitman, B.10
Clemmensen, P.M.11
Dellborg, M.12
Hod, H.13
Porela, P.14
Underwood, R.15
Bax, J.J.16
Beller, G.A.17
Bonow, R.18
Van Der Wall, E.E.19
Bassand, J.P.20
Wijns, W.21
Ferguson, T.B.22
Steg, P.G.23
Uretsky, B.F.24
Williams, D.O.25
Armstrong, P.W.26
Antman, E.M.27
Fox, K.A.28
Hamm, C.W.29
Ohman, E.M.30
Simoons, M.L.31
Poole-Wilson, P.A.32
Gurfinkel, E.P.33
Lopez-Sendon, J.L.34
Pais, P.35
Mendis, S.36
Zhu, J.R.37
Wallentin, L.C.38
Fernandez-Aviles, F.39
Fox, K.M.40
Parkhomenko, A.N.41
Priori, S.G.42
Tendera, M.43
Voipio-Pulkki, L.M.44
Vahanian, A.45
Camm, A.J.46
De Caterina, R.47
Dean, V.48
Dickstein, K.49
Filippatos, G.50
Funck-Brentano, C.51
Hellemans, I.52
Kristensen, S.D.53
McGregor, K.54
Sechtem, U.55
Silber, S.56
Widimsky, P.57
Zamorano, J.L.58
Morais, J.59
Brener, S.60
Harrington, R.61
Morrow, D.62
Lim, M.63
Martinez-Rios, M.A.64
Steinhubl, S.65
Levine, G.N.66
Gibler, W.B.67
Goff, D.68
Tubaro, M.69
Dudek, D.70
Al-Attar, N.71
more..
-
29
-
-
34247644924
-
Thrombosis in coronary drug-eluting stents: Report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006
-
Laskey WK, Yancy CW, Maisel WH. Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7-8, 2006. Circulation. 2007;115:2352-2357.
-
(2007)
Circulation.
, vol.115
, pp. 2352-2357
-
-
Laskey, W.K.1
Yancy, C.W.2
Maisel, W.H.3
-
31
-
-
2342430250
-
Obesity, insulin resistance, and cardiovascular disease
-
Reaven G, Abbasi F, McLaughlin T. Obesity, insulin resistance, and cardiovascular disease. Recent Prog Horm Res. 2004;59:207-223.
-
(2004)
Recent Prog Horm Res
, vol.59
, pp. 207-223
-
-
Reaven, G.1
Abbasi, F.2
McLaughlin, T.3
-
32
-
-
83855165740
-
Platelet activation in obesity and metabolic syndrome
-
Santilli F, Vazzana N, Liani R, Guagnano MT, Davì G. Platelet activation in obesity and metabolic syndrome. Obes Rev. 2012;13:27-42.
-
(2012)
Obes Rev.
, vol.13
, pp. 27-42
-
-
Santilli, F.1
Vazzana, N.2
Liani, R.3
Guagnano, M.T.4
Davì, G.5
-
33
-
-
0037028885
-
The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI)
-
BARI Investigators
-
Gurm HS, Whitlow PL, Kip KE; BARI Investigators. The impact of body mass index on short- and long-term outcomes inpatients undergoing coronary revascularization. Insights from the bypass angioplasty revascularization investigation (BARI). J Am Coll Cardiol. 2002;39:834-840.
-
(2002)
J Am Coll Cardiol
, vol.39
, pp. 834-840
-
-
Gurm, H.S.1
Whitlow, P.L.2
Kip, K.E.3
-
34
-
-
34548835744
-
Obesity paradox in patients with hypertension and coronary artery disease
-
Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ. Obesity paradox in patients with hypertension and coronary artery disease. Am J Med. 2007;120:863-870.
-
(2007)
Am J Med
, vol.120
, pp. 863-870
-
-
Uretsky, S.1
Messerli, F.H.2
Bangalore, S.3
Champion, A.4
Cooper-Dehoff, R.M.5
Zhou, Q.6
Pepine, C.J.7
-
35
-
-
33749001704
-
Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: Evidence for tissue specificity of leptin resistance
-
Momin AU, Melikian N, Shah AM, Grieve DJ, Wheatcroft SB, John L, El Gamel A, Desai JB, Nelson T, Driver C, Sherwood RA, Kearney MT. Leptin is an endothelial-independent vasodilator in humans with coronary artery disease: evidence for tissue specificity of leptin resistance. Eur Heart J. 2006;27:2294-2299.
-
(2006)
Eur Heart J
, vol.27
, pp. 2294-2299
-
-
Momin, A.U.1
Melikian, N.2
Shah, A.M.3
Grieve, D.J.4
Wheatcroft, S.B.5
John, L.6
El Gamel, A.7
Desai, J.B.8
Nelson, T.9
Driver, C.10
Sherwood, R.A.11
Kearney, M.T.12
-
36
-
-
85066456886
-
Appropriate body-mass index for asian populations and its implications for policy and intervention strategies
-
Consultation WHOE
-
Consultation WHOE. Appropriate body-mass index for asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157-163.
-
(2004)
Lancet
, vol.363
, pp. 157-163
-
-
-
37
-
-
13844253572
-
Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor
-
Eilat-Adar S, Eldar M, Goldbourt U. Association of intentional changes in body weight with coronary heart disease event rates in overweight subjects who have an additional coronary risk factor. Am J Epidemiol. 2005;161:352-358.
-
(2005)
Am J Epidemiol
, vol.161
, pp. 352-358
-
-
Eilat-Adar, S.1
Eldar, M.2
Goldbourt, U.3
|